US ITC Delays Final Ruling on Daewoong-Medytox Dispute

The U.S. International Trade Commission(ITC) again postponed its final ruling on a dispute over a botulinum toxin strain between two South Korean drugmakers. According to the pharmaceutical and bio industries on Friday, the ITC announced that its final verdict scheduled for Thursday has been postponed to December 16.


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.